Literature DB >> 1991437

Superiority of radiobinding assay over ELISA for detection of IAAs in newly diagnosed type I diabetic children.

C Levy-Marchal1, M P Bridel, F Sodoyez-Goffaux, M Koch, J Tichet, P Czernichow, J C Sodoyez.   

Abstract

OBJECTIVE: Liquid- or solid-phase assays have been used for insulin autoantibody (IAA) determination, and the method of IAA measurement has not been standardized. RESEARCH DESIGN AND METHODS: IAAs were determined by radiobinding assay (RBA) and enzyme-linked immunosorbent assay (ELISA) in two large age-matched groups of nondiabetic and newly diagnosed insulin-dependent (type I) diabetic children.
RESULTS: Positivity for IAA by RBA (greater than or equal to nondiabetic mean + 3SD) was 2 of 178 (1.1%) and 55 of 173 (32%) in nondiabetic and diabetic children, respectively. Prevalence of IAA by RBA was significantly higher in the youngest age-group (63% between 0-4 yr). Positivity for IAA by ELISA was 1 of 178 (0.6%) and 8 of 169 (4.7%) in nondiabetic and diabetic children, respectively. Concordance rates between both assays were 0 of 3 (0%) in control subjects and 5 of 58 (8.6%) in diabetic children.
CONCLUSIONS: We conclude that RBA is more appropriate than ELISA for IAA detection at the onset of the disease. In addition, because available data suggest that IAAs detected by RBA only are high-affinity antibodies, it is tempting to speculate that IAAs reflect a mature immune reaction against endogenous insulin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991437     DOI: 10.2337/diacare.14.1.61

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  11 in total

1.  Islet cell antibodies in normal French schoolchildren.

Authors:  C Lévy-Marchal; J Tichet; I Fajardy; X F Gu; F Dubois; P Czernichow
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

2.  Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies.

Authors:  J C Ongagna; C Levy-Marchal
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

3.  Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.

Authors:  E Bonifacio; S Genovese; S Braghi; E Bazzigaluppi; V Lampasona; P J Bingley; L Rogge; M R Pastore; E Bognetti; G F Bottazzo
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

4.  Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry.

Authors:  F K Gorus; J C Sodoyez; D G Pipeleers; B Keymeulen; A Foriers; C F Van Schravendijk
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

5.  Disease-associated anti-bovine serum albumin antibodies in type 1 (insulin-dependent) diabetes mellitus are detected by particle concentration fluoroimmunoassay, and not by enzyme linked immunoassay.

Authors:  J Karjalainen; T Saukkonen; E Savilahti; H M Dosch
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

6.  Influence of affinity of antibodies upon their detection by liquid phase radiobinding assay and solid phase enzyme linked immunosorbent assay. Demonstration using monoclonal antibodies raised against rDNA human proinsulin.

Authors:  J C Sodoyez; M Koch; I Lemaire; F Sodoyez-Goffaux; A Rapaille; C François-Gérard; D Sondag
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

7.  Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets.

Authors:  Norio Kanatsuna; Jalal Taneera; Fariba Vaziri-Sani; Nils Wierup; Helena Elding Larsson; Ahmed Delli; Hanna Skärstrand; Alexander Balhuizen; Hedvig Bennet; Donald F Steiner; Carina Törn; Malin Fex; Åke Lernmark
Journal:  J Biol Chem       Date:  2013-08-09       Impact factor: 5.157

8.  Novel prokaryotic expression of thioredoxin-fused insulinoma associated protein tyrosine phosphatase 2 (IA-2), its characterization and immunodiagnostic application.

Authors:  Luciano Lucas Guerra; Natalia Inés Faccinetti; Aldana Trabucchi; Bruno David Rovitto; Adriana Victoria Sabljic; Edgardo Poskus; Ruben Francisco Iacono; Silvina Noemí Valdez
Journal:  BMC Biotechnol       Date:  2016-11-24       Impact factor: 2.563

9.  Prokaryotic expression and characterization of the heterodimeric construction of ZnT8 and its application for autoantibodies detection in diabetes mellitus.

Authors:  Natalia I Faccinetti; Luciano L Guerra; Adriana V Sabljic; Silvina S Bombicino; Bruno D Rovitto; Ruben F Iacono; Edgardo Poskus; Aldana Trabucchi; Silvina N Valdez
Journal:  Microb Cell Fact       Date:  2017-11-13       Impact factor: 5.328

10.  Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial.

Authors:  Hansje-Eva Teulings; Esther P M Tjin; Karina J Willemsen; Stephanie van der Kleij; Sylvia Ter Meulen; E Helen Kemp; Gabrielle Krebbers; Carel J M van Noesel; Cornelis L M C Franken; Jan W Drijfhout; Cornelis J M Melief; Ludmila Nieuweboer-Krobotova; Omgo E Nieweg; Jos A van der Hage; J P Wietze van der Veen; Germaine N Relyveld; Rosalie M Luiten
Journal:  Oncoimmunology       Date:  2018-01-15       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.